Please assess the completion status of the following clinical trial:

Trial Title: Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.~* Less than 5mm despite 10 days with standard doses of estrogen therapy (6mg / 24h) Endometrio~Exclusion Criteria:~* History of pelvic inflammatory disease~* Risk of infection

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- Endometrium with less than 5mm (Type: EXPERIMENTAL): Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.~Less than 5mm despite 10 days with standard doses of estrogen
- Endometrium with more than 5mm (Type: NO_INTERVENTION): Women receiving cycle of oocytes outside or embryos (own / others), in the treatment of substituted cycle type.~More than 5mm despite 10 days with standard doses of estrogen

Based on this trial design, predict the completion outcome and termination type (if applicable).